Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
9 participants
OBSERVATIONAL
2017-01-31
2018-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Feasibility Study of a Fecal Incontinence Management System for Medical Use
NCT00556972
Study of Pant Type Absorbing Urinary Incontinence Products
NCT05031442
The (Cost)Effect of Smart Diaper Continence Care for People With Profound Intellectual and Multiple Disabilities
NCT05481840
Consumer Evaluation of Intermittent Catheter Product Modifications
NCT04619992
Incontinence Management System ICU Field Evaluation
NCT03628833
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1
Subjects will use the incontinence pad with incontinence detection notifications turned on
Incontinence Detection System
Phase 2
Subjects will use the incontinence pad with incontinence notification turned off
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Incontinence Detection System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Incontinent (fecal, urine, or dual incontinence)
* Patients with dual incontinence who require use of a fecal management system (but no urinary catheter)
* Absence of skin irritation, breakdown, and pressure injuries present in the buttocks, sacrum, and/or perineal areas at the time of enrollment; minor irritation may be acceptable at the discretion of the Study Investigator
* Willing and able to provide written informed consent or legal authorized representative is willing and able to provide written informed consent
Exclusion Criteria
* Require use of an absorbent undergarment (e.g. Depends) or catheter as the primary incontinence management strategy
* Is considered to be near death or requires hospice care
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hill-Rom
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parkview Regional Medical Center
Fort Wayne, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-CWS2016-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.